Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-25-000096
Filing Date
2025-08-12
Accepted
2025-08-12 17:27:44
Documents
48
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20250630.htm   iXBRL 10-Q 574058
2 EX-31.1 slrx20250630ex-311.htm EX-31.1 8877
3 EX-31.2 slrx20250630ex-312.htm EX-31.2 8667
4 EX-32.1 slrx20250630ex-321.htm EX-32.1 6206
  Complete submission text file 0001615219-25-000096.txt   3281307

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20250630.xsd EX-101.SCH 21591
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20250630_cal.xml EX-101.CAL 23162
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20250630_def.xml EX-101.DEF 74471
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20250630_lab.xml EX-101.LAB 371877
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20250630_pre.xml EX-101.PRE 236525
51 EXTRACTED XBRL INSTANCE DOCUMENT flks-20250630_htm.xml XML 289613
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 251208112
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)